A clinical study to evaluate the efficacy of shodhana navana nasya and avapeedana nasya in manyastambha
Phase 3
- Conditions
- Health Condition 1: M488- Other specified spondylopathies
- Registration Number
- CTRI/2020/04/024794
- Lead Sponsor
- Dr Haripriya Vasudev
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 Subjects with clinical signs and symptoms of manyastambha.
2 Age between 21-50 years old.
3 Subjects of either gender irrespective of religion and socio economic status.
4 Subjects fit for nasya
Exclusion Criteria
1 Pregnant and lactating women.
2 Subjects with congenital deformity, traumatic injury, cervical stenosis and myelopathy, infections of bone and gross bony deformity and epistaxis.
3 Other systemic disorders which interfere in the line of treatment like uncontrolled diabetes, uncontrolled hypertension and cardio vascular disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method There is no significant difference in the outcome of both shodhana navana nasya and avapeedana nasya.Timepoint: 7th day <br/ ><br>14th day
- Secondary Outcome Measures
Name Time Method Shodhana navana nasya is better than avapeedana nasyaTimepoint: 7th day <br/ ><br>14th day